Ali Zeaiter
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
Papers in
- Oncology 68
- Lung Cancer Research Studies 47
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 7
-
- Lung Cancer Treatments and Mutations 50
- Lung Cancer Diagnosis and Treatment 14
- Co-authors
- Sai‐Hong Ignatius OuBogdana BalasAlice T. ShawShirish M. GadgeelD. Ross CamidgePeter N. MorcosJin Seok AhnSolange Peters
- Journals
- Journal of Clinical Oncology (23 papers)Journal of Thoracic Oncology (12 papers)Annals of Oncology (10 papers)European Journal of Cancer (4 papers)Investigational New Drugs (3 papers)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Ali Zeaiter
75 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 2.8k
- Pulmonary and Respiratory Medicine 3.2k
- Cancer Research 750
- Genetics 368
- Pathology and Forensic Medicine 314
Countries citing papers authored by Ali Zeaiter
This map shows the geographic impact of Ali Zeaiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Zeaiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Zeaiter more than expected).
Fields of papers citing papers by Ali Zeaiter
This network shows the impact of papers produced by Ali Zeaiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Zeaiter. The network helps show where Ali Zeaiter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ali Zeaiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 14 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 3 | |
| 12 | 2018 | 1 | |
| 13 | 2018 | 243 | |
| 14 | 2017 | 10 | |
| 15 | 2017 | 8 | |
| 16 | 2016 | 3 | |
| 17 | 2016 | 11 | |
| 18 | Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial Hit paper breakdown → | 2015 | 462 |
| 19 | 2014 | 35 | |
| 20 | 2013 | 26 |
About Ali Zeaiter
Ali Zeaiter is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Reproductive Medicine, having authored 77 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (50 papers), Lung Cancer Research Studies (47 papers), Cancer therapeutics and mechanisms (17 papers), Lung Cancer Diagnosis and Treatment (14 papers), Colorectal Cancer Treatments and Studies (10 papers), Neuroendocrine Tumor Research Advances (8 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Oncology (2.8k citations), Pulmonary and Respiratory Medicine (3.2k citations), Cancer Research (750 citations), Genetics (368 citations) and Pathology and Forensic Medicine (314 citations). Ali Zeaiter has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Sai‐Hong Ignatius Ou, Bogdana Balas, Alice T. Shaw, Shirish M. Gadgeel, D. Ross Camidge, Peter N. Morcos, Jin Seok Ahn, Solange Peters, Rafał Dziadziuszko and Tony Mok. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, European Journal of Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.